This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finnberg, N.
Right arrow Articles by El-Deiry, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finnberg, N.
Right arrow Articles by El-Deiry, W. S.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 2005, p. 2000-2013, Vol. 25, No. 5
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.5.2000-2013.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

DR5 Knockout Mice Are Compromised in Radiation-Induced Apoptosis

Niklas Finnberg,1 Joshua J. Gruber,1 Peiwen Fei,1 Dorothea Rudolph,2 Anka Bric,3 Seok-Hyun Kim,1 Timothy F. Burns,1 Hope Ajuha,1 Robert Page,1 Gen Sheng Wu,1 Youhai Chen,1 W. Gillies McKenna,1 Eric Bernhard,1 Scott Lowe,3 Tak Mak,2 and Wafik S. El-Deiry1*

University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania,1 University of Toronto, Toronto, Ontario, Canada,2 Cold Spring Harbor Laboratory, Cold Spring Harbor, New York3

Received 17 October 2004/ Returned for modification 16 November 2004/ Accepted 2 December 2004

DR5 (also called TRAIL receptor 2 and KILLER) is an apoptosis-inducing membrane receptor for tumor necrosis factor-related apoptosis-inducing ligand (also called TRAIL and Apo2 ligand). DR5 is a transcriptional target of p53, and its overexpression induces cell death in vitro. However, the in vivo biology of DR5 has remained largely unexplored. To better understand the role of DR5 in development and in adult tissues, we have created a knockout mouse lacking DR5. This mouse is viable and develops normally with the exception of having an enlarged thymus. We show that DR5 is not expressed in developing embryos but is present in the decidua and chorion early in development. DR5-null mouse embryo fibroblasts expressing E1A are resistant to treatment with TRAIL, suggesting that DR5 may be the primary proapoptotic receptor for TRAIL in the mouse. When exposed to ionizing radiation, DR5-null tissues exhibit reduced amounts of apoptosis compared to wild-type thymus, spleen, Peyer's patches, and the white matter of the brain. In the ileum, colon, and stomach, DR5 deficiency was associated with a subtle phenotype of radiation-induced cell death. These results indicate that DR5 has a limited role during embryogenesis and early stages of development but plays an organ-specific role in the response to DNA-damaging stimuli.

* Corresponding author. Mailing address: University of Pennsylvania, 415 Curie Blvd., CRB 437, Philadelphia, PA 19104. Phone: (215) 898-9015. Fax: (215) 573-9139. E-mail: wafik{at}mail.med.upenn.edu.

Molecular and Cellular Biology, March 2005, p. 2000-2013, Vol. 25, No. 5
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.5.2000-2013.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Hu, G., Barnes, B. J. (2009). IRF-5 Is a Mediator of the Death Receptor-induced Apoptotic Signaling Pathway. J. Biol. Chem. 284: 2767-2777 [Abstract] [Full Text]  
  • Herold, S., Steinmueller, M., von Wulffen, W., Cakarova, L., Pinto, R., Pleschka, S., Mack, M., Kuziel, W. A., Corazza, N., Brunner, T., Seeger, W., Lohmeyer, J. (2008). Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. JEM 205: 3065-3077 [Abstract] [Full Text]  
  • Brincks, E. L., Katewa, A., Kucaba, T. A., Griffith, T. S., Legge, K. L. (2008). CD8 T Cells Utilize TRAIL to Control Influenza Virus Infection. J. Immunol. 181: 4918-4925 [Abstract] [Full Text]  
  • Cretney, E., Uldrich, A. P., McNab, F. W., Godfrey, D. I., Smyth, M. J. (2008). No requirement for TRAIL in intrathymic negative selection. Int Immunol 20: 267-276 [Abstract] [Full Text]  
  • Daniel, D., Yang, B., Lawrence, D. A., Totpal, K., Balter, I., Lee, W. P., Gogineni, A., Cole, M. J., Yee, S. F., Ross, S., Ashkenazi, A. (2007). Cooperation of the proapoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin lymphoma xenografts. Blood 110: 4037-4046 [Abstract] [Full Text]  
  • Finnberg, N., El-Deiry, W. S. (2006). Selective TRAIL-Induced Apoptosis in Dysplastic Neoplasia of the Colon May Lead to New Neoadjuvant or Adjuvant Therapies.. Clin. Cancer Res. 12: 4132-4136 [Full Text]  
  • Rubio-Moscardo, F., Blesa, D., Mestre, C., Siebert, R., Balasas, T., Benito, A., Rosenwald, A., Climent, J., Martinez, J. I., Schilhabel, M., Karran, E. L., Gesk, S., Esteller, M., deLeeuw, R., Staudt, L. M., Fernandez-Luna, J. L., Pinkel, D., Dyer, M. J. S., Martinez-Climent, J. A. (2005). Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood 106: 3214-3222 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»